Collagen: How it works in medical treatments

Fig. b: Collagen matrix after treatment with UVA light and riboflavin. Structure with cavities and pores of 1 - 20 µm supports cellular processes. Reaction to freeze-drying (Fig. d) indicates high resistance to mechanical stress.
(c) NMI

Scientists at the NMI have unraveled the mode of action of collagen crosslinking in the treatment of corneal defects and the results open up new opportunities for the use of collagen in medicine.

Collagen has been used in ophthalmology since the 1990s, particularly in the treatment of corneal defects. However, why and how this technique works was only known in theory. Researchers at the NMI Natural and Medical Sciences Institute in Reutlingen led by Lu Fan have found the necessary evidence and can now reliably explain how this technique works. “Our results close a regulatory gap and at the same time open up new opportunities in the application of collagen, even beyond ophthalmology,” explains scientist Lu Fan.

Collagen: many applications, many opportunities

Collagen is the most common protein in the body of animals, including humans. It plays an important role e.g. in the structure of bones, teeth, tendons, ligaments and skin. Scientists see an opportunity to “repair” defective areas with collagen. UV collagen crosslinking (CXL) is used to treat a defective cornea. To do this, the cornea is first treated with riboflavin (also known as vitamin B2) and the area is then irradiated with UVA light. The resulting free radicals then ensure that additional cross-linking occurs within the collagen fibers of the cornea, making it more stable.

Treatments become more precise, more reliable and gentler – even on more parts of the body?

“These findings allow us to optimize the treatment, making it both more reliable and gentler,” explains Xin Xiong, NMI scientist from the research team. The more precise dosing that is now possible also minimizes the potential risks. However, the researchers are already looking beyond the treatment of the cornea. As collagen is found in many parts of the body, there could also be potential for treating other diseases. This repair or regeneration of collagen-based tissue seems conceivable in wound healing, bone replacement, dentistry and cardiovascular diseases, for example. However, further research is required.

MIK as a partner of SMEs

The results are also a success for the MDR & IVDR Competence Center (MIK) of the NMI and Hahn-Schickard. One of MIK’s aims is to develop analytical and testing methods that are not yet available and to support companies in the development of innovative ideas through to certification. MIK was created in response to stricter regulations on medical devices (MDR) and in-vitro diagnostics (IVDR), which pose major challenges for small and medium-sized companies in the industry in particular. The MIK was initially funded by the Baden-Württemberg Ministry of Economic Affairs, Labor and Tourism.

About the NMI:

The NMI Natural and Medical Sciences Institute in Reutlingen is a non-university research institution and conducts application-oriented research at the interface of biosciences and materials science. It has a unique, interdisciplinary range of expertise for R&D and services for regional and international companies. The institute addresses the healthcare industry as well as companies from the automotive, mechanical engineering and toolmaking sectors. At the same time, the NMI actively supports spin-offs from the institute.

In research, the NMI cooperates with numerous top-class institutions such as the University of Tübingen, the University Hospital Tübingen and the institutes of the innBW network.
The NMI is supported by the Baden-Württemberg Ministry of Economics, Labor and Tourism and is a member of the Baden-Württemberg Innovation Alliance, an association of 12 non-university and business-related research institutes.

https://www.nmi.de/en/
http://www.linkedin.com/company/natural-and-medical-sciences-institute-at-univer…

Originalpublikation:

https://doi.org/10.1002/adfm.202401742

https://www.nmi.de/en/news/detail/kollagen-forschende-am-nmi-entschluesseln-funktionsweise-in-der-medizinischen-behandlung

Media Contact

Jörg Schäfer Pressestelle
NMI Naturwissenschaftliches und Medizinisches Institut in Reutlingen

All latest news from the category: Life Sciences and Chemistry

Articles and reports from the Life Sciences and chemistry area deal with applied and basic research into modern biology, chemistry and human medicine.

Valuable information can be found on a range of life sciences fields including bacteriology, biochemistry, bionics, bioinformatics, biophysics, biotechnology, genetics, geobotany, human biology, marine biology, microbiology, molecular biology, cellular biology, zoology, bioinorganic chemistry, microchemistry and environmental chemistry.

Back to home

Comments (0)

Write a comment

Newest articles

ispace and University of Leicester collaborate on lunar night survival technology

ispace, inc. (ispace), a global lunar exploration company, and the University of Leicester, have agreed to collaborate on approaches to lunar night survivability for future ispace lunar lander and rover…

Technique to analyze RNA structures in ultra-high definition

This is where the Nottingham team, led by Dr Aditi Borkar, Assistant Professor in Molecular Biochemistry & Biophysics in the School of Veterinary Medicine and Science, has achieved a transformative…

Iron could be key to less expensive, greener lithium-ion batteries

What if a common element rather than scarce, expensive ones was a key component in electric car batteries? A collaboration co-led by an Oregon State University chemistry researcher is hoping…

Partners & Sponsors